Literature DB >> 19175192

Medication reconciliation in hemodialysis patients.

Séadna Ledger1, Gail Choma.   

Abstract

Medication reconciliation is an effective process to reduce adverse drug events (ADEs) and harm associated with the loss of medication information as patients transfer between health care settings. Patients with end stage renal disease (ESRD) are at a high risk of experiencing drug-related problems (DRPs) because they take many medications, have multiple comorbidities, and require frequent medication changes. We evaluated the potential impact of medication reconciliation and optimization in the ambulatory care setting at the time of patient transfer from an in-centre dialysis unit to a satellite dialysis unit. Overall, 15 patients (78.8%) had at least one unintended medication variance. The majority of unintended variances (56%) were caused by the physician/nurse practitioner (NP) omitting an order for medication that the patient was taking. In this small study, medication reconciliation was effective at identifying and rectifying medication errors and optimizing pharmacotherapy at the time of transfer from an in-centre hemodialysis to a satellite dialysis unit.

Entities:  

Mesh:

Year:  2008        PMID: 19175192

Source DB:  PubMed          Journal:  CANNT J        ISSN: 1498-5136


  11 in total

Review 1.  Patient and facility safety in hemodialysis: opportunities and strategies to develop a culture of safety.

Authors:  Renee Garrick; Alan Kliger; Beth Stefanchik
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 8.237

2.  The missing piece: Clinical pharmacists enhancing the interprofessional nephrology clinic model.

Authors:  Chelsea E Hawley; Laura K Triantafylidis; Julie M Paik
Journal:  J Am Pharm Assoc (2003)       Date:  2019-06-21

Review 3.  The medication reconciliation process and classification of discrepancies: a systematic review.

Authors:  Enas Almanasreh; Rebekah Moles; Timothy F Chen
Journal:  Br J Clin Pharmacol       Date:  2016-06-29       Impact factor: 4.335

4.  Unplanned 30-Day Readmissions after Parathyroidectomy in Patients with Chronic Kidney Disease: A Nationwide Analysis.

Authors:  Rocco Ferrandino; Scott Roof; Yue Ma; Lili Chan; Priti Poojary; Aparna Saha; Kinsuk Chauhan; Steven G Coca; Girish N Nadkarni; Marita S Teng
Journal:  Otolaryngol Head Neck Surg       Date:  2017-09-26       Impact factor: 3.497

Review 5.  Maintaining safety in the dialysis facility.

Authors:  Alan S Kliger
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-06       Impact factor: 8.237

Review 6.  Medication Reconciliation: The Foundation of Medication Safety for Patients Requiring Dialysis.

Authors:  Jill Frament; Rasheeda K Hall; Harold J Manley
Journal:  Am J Kidney Dis       Date:  2020-09-10       Impact factor: 8.860

7.  Improving patient safety and efficiency of medication reconciliation through the development and adoption of a computer-assisted tool with automated electronic integration of population-based community drug data: the RightRx project.

Authors:  Robyn Tamblyn; Nancy Winslade; Todd C Lee; Aude Motulsky; Ari Meguerditchian; Melissa Bustillo; Sarah Elsayed; David L Buckeridge; Isabelle Couture; Christina J Qian; Teresa Moraga; Allen Huang
Journal:  J Am Med Inform Assoc       Date:  2018-05-01       Impact factor: 4.497

8.  Using novel Canadian resources to improve medication reconciliation at discharge: study protocol for a randomized controlled trial.

Authors:  Robyn Tamblyn; Allen R Huang; Ari N Meguerditchian; Nancy E Winslade; Christian Rochefort; Alan Forster; Tewodros Eguale; David Buckeridge; André Jacques; Kiyuri Naicker; Kristen E Reidel
Journal:  Trials       Date:  2012-08-27       Impact factor: 2.279

9.  Potential role of a pharmacist to enhance medication-related aspects of clinical trials conducted in a dedicated clinical research unit.

Authors:  Kimberly A Redic; Amy Skyles; John Zaccardelli
Journal:  Contemp Clin Trials Commun       Date:  2017-03-18

10.  Polypharmacy and Medication-Related Problems in Hemodialysis Patients: A Call for Deprescribing.

Authors:  Majed Alshamrani; Abdullah Almalki; Mohamed Qureshi; Oyindamola Yusuf; Sherine Ismail
Journal:  Pharmacy (Basel)       Date:  2018-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.